Vasculitis syndromes: Which maintenance therapy for ANCA vasculitis?

Patrick H. Nachman

doi:10.1038/nrneph.2009.52

Vasculitis syndromes: Which maintenance therapy for ANCA vasculitis?

Patrick H. Nachman

Research output: Contribution to journal › Short survey › peer-review

4 Scopus citations

Abstract

Antineutrophil cytoplasmic antibody-associated vasculitides are usually treated with a combination of high-dose corticosteroids and cyclophosphamide therapy to induce remission, commonly followed by maintenance treatment with a less-toxic immunosuppressant. azathioprine and methotrexate are both options for maintenance therapy, but whether one of these immunosuppressants is superior to the other is unclear.

Original language	English (US)
Pages (from-to)	254-256
Number of pages	3
Journal	Nature Reviews Nephrology
Volume	5
Issue number	5
DOIs	https://doi.org/10.1038/nrneph.2009.52
State	Published - May 2009
Externally published	Yes

Publisher link

10.1038/nrneph.2009.52

Find It

Find It at U of M Libraries

Cite this

@article{47043c333c61419d88c0069bc105103a,

title = "Vasculitis syndromes: Which maintenance therapy for ANCA vasculitis?",

abstract = "Antineutrophil cytoplasmic antibody-associated vasculitides are usually treated with a combination of high-dose corticosteroids and cyclophosphamide therapy to induce remission, commonly followed by maintenance treatment with a less-toxic immunosuppressant. azathioprine and methotrexate are both options for maintenance therapy, but whether one of these immunosuppressants is superior to the other is unclear.",

author = "Nachman, {Patrick H.}",

year = "2009",

month = may,

doi = "10.1038/nrneph.2009.52",

language = "English (US)",

volume = "5",

pages = "254--256",

journal = "Nature Clinical Practice Nephrology",

issn = "1759-507X",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Vasculitis syndromes

T2 - Which maintenance therapy for ANCA vasculitis?

AU - Nachman, Patrick H.

PY - 2009/5

Y1 - 2009/5

N2 - Antineutrophil cytoplasmic antibody-associated vasculitides are usually treated with a combination of high-dose corticosteroids and cyclophosphamide therapy to induce remission, commonly followed by maintenance treatment with a less-toxic immunosuppressant. azathioprine and methotrexate are both options for maintenance therapy, but whether one of these immunosuppressants is superior to the other is unclear.

AB - Antineutrophil cytoplasmic antibody-associated vasculitides are usually treated with a combination of high-dose corticosteroids and cyclophosphamide therapy to induce remission, commonly followed by maintenance treatment with a less-toxic immunosuppressant. azathioprine and methotrexate are both options for maintenance therapy, but whether one of these immunosuppressants is superior to the other is unclear.

UR - http://www.scopus.com/inward/record.url?scp=67650354217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650354217&partnerID=8YFLogxK

U2 - 10.1038/nrneph.2009.52

DO - 10.1038/nrneph.2009.52

M3 - Short survey

C2 - 19384325

AN - SCOPUS:67650354217

SN - 1759-507X

VL - 5

SP - 254

EP - 256

JO - Nature Clinical Practice Nephrology

JF - Nature Clinical Practice Nephrology

IS - 5

ER -

Vasculitis syndromes: Which maintenance therapy for ANCA vasculitis?

Abstract

Publisher link

Find It

Other files and links

Fingerprint

Cite this